tiprankstipranks
Trending News
More News >
REPRO-MED Systems (KRMD)
NASDAQ:KRMD
US Market
Advertisement

REPRO-MED Systems (KRMD) Stock Statistics & Valuation Metrics

Compare
287 Followers

Total Valuation

REPRO-MED Systems has a market cap or net worth of $190.49M. The enterprise value is $160.79M.
Market Cap$190.49M
Enterprise Value$160.79M

Share Statistics

REPRO-MED Systems has 46,234,960 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding46,234,960
Owned by Insiders17.32%
Owned by Institutions0.93%

Financial Efficiency

REPRO-MED Systems’s return on equity (ROE) is -0.36 and return on invested capital (ROIC) is -31.00%.
Return on Equity (ROE)-0.36
Return on Assets (ROA)-0.22
Return on Invested Capital (ROIC)-31.00%
Return on Capital Employed (ROCE)-0.32
Revenue Per Employee420.57K
Profits Per Employee-75.83K
Employee Count80
Asset Turnover1.24
Inventory Turnover4.39

Valuation Ratios

The current PE Ratio of REPRO-MED Systems is ―. REPRO-MED Systems’s PEG ratio is ―.
PE Ratio
PS Ratio
PB Ratio
Price to Fair Value10.49
Price to FCF
Price to Operating Cash Flow-291.19
PEG Ratio

Income Statement

In the last 12 months, REPRO-MED Systems had revenue of 33.65M and earned -6.07M in profits. Earnings per share was -0.13.
Revenue33.65M
Gross Profit21.33M
Operating Income-6.45M
Pretax Income-6.06M
Net Income-6.07M
EBITDA-5.56M
Earnings Per Share (EPS)-0.13

Cash Flow

In the last 12 months, operating cash flow was -682.14K and capital expenditures -1.49M, giving a free cash flow of -2.17M billion.
Operating Cash Flow-682.14K
Free Cash Flow-2.17M
Free Cash Flow per Share-0.05

Dividends & Yields

REPRO-MED Systems pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.90
52-Week Price Change78.35%
50-Day Moving Average3.47
200-Day Moving Average3.37
Relative Strength Index (RSI)65.35
Average Volume (3m)140.96K

Important Dates

REPRO-MED Systems upcoming earnings date is Nov 5, 2025, After Close (Confirmed).
Last Earnings DateAug 6, 2025
Next Earnings DateNov 5, 2025
Ex-Dividend Date

Financial Position

REPRO-MED Systems as a current ratio of 2.66, with Debt / Equity ratio of 20.98%
Current Ratio2.66
Quick Ratio2.27
Debt to Market Cap<0.01
Net Debt to EBITDA1.01
Interest Coverage Ratio0.00

Taxes

In the past 12 months, REPRO-MED Systems has paid 2.89K in taxes.
Income Tax2.89K
Effective Tax Rate>-0.01

Enterprise Valuation

REPRO-MED Systems EV to EBITDA ratio is -30.72, with an EV/FCF ratio of -105.59.
EV to Sales5.07
EV to EBITDA-30.72
EV to Free Cash Flow-105.59
EV to Operating Cash Flow-534.07

Balance Sheet

REPRO-MED Systems has $8.05M in cash and marketable securities with $3.47M in debt, giving a net cash position of -$4.59M billion.
Cash & Marketable Securities$8.05M
Total Debt$3.47M
Net Cash-$4.59M
Net Cash Per Share-$0.10
Tangible Book Value Per Share$0.35

Margins

Gross margin is 63.15%, with operating margin of -19.16%, and net profit margin of -18.03%.
Gross Margin63.15%
Operating Margin-19.16%
Pretax Margin-18.02%
Net Profit Margin-18.03%
EBITDA Margin-16.52%
EBIT Margin-19.16%

Analyst Forecast

The average price target for REPRO-MED Systems is $4.88, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$4.88
Price Target Upside18.45% Upside
Analyst ConsensusModerate Buy
Analyst Count5
Revenue Growth Forecast19.57%
EPS Growth Forecast61.81%

Scores

Smart Score8
AI Score59.25
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis